Stocks
Deciphera Pharmaceuticals (DCPH) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -183.7 | -264.2 | -297.1 | -170.8 | -208.9 | -195.3 | ||
| Changes by years, y/y, % | +84% | +44% | +12% | -43% | +22% | +15.9% | |||
Deciphera Pharmaceuticals. EBITDA US GAAP, bln rub
Deciphera Pharmaceuticals. EBITDA US GAAP, changes, %
Deciphera Pharmaceuticals. EBITDA US GAAP, sum by quarters, bln rub
Deciphera Pharmaceuticals (DCPH) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -53.3 | -52.2 | -53.2 | -42.7 | -47.3 | -195.3 | |
| Changes by years, y/y, % | +14% | +26% | +32% | 0% | -11% | |||
| Changes by quarters, q/q, % | +25% | -2% | +2% | -20% | +11% | |||
